About Genome Technologies

Mark Adams

Director of Genome Technologies
Interim Scientific Director & Professor, The Jackson Laboratory for Genomic Medicine

Mark Adams, Ph.D., has directed Genome Technologies since 2023, ensuring the team is able to provide cutting-edge genomic research services and access to next-generation sequencing platforms to JAX investigators. Dr. Adams was a co-founder of The Institute for Genomic Research and Celera Genomics where he led the DNA sequencing and genome annotation groups responsible for sequencing of the initial human, mouse, and Drosophila genomes. Prior to joining JAX in 2016, he was scientific director and professor at the J. Craig Venter Institute where he directed programs that characterized genomic changes in the evolution of antibiotic resistance in hospital-acquired infections.

Join Our Team

Our team spans two campuses and includes genome technologists and scientists, computational and bioinformatic scientists, and a Sanger sequencing lead. Our core staff members possess a diverse skill set that enables us to effectively operate and manage multiple genomic technologies and workflows and to adapt them to fit the project needs of JAX scientists. Key skills include:

• Expertise in operating various next-generation sequencing platforms such as Illumina, Pacific Biosciences, and Oxford Nanopore Technologies, including sample preparation, library construction, sequencing, and data analysis
• Competence in molecular biology techniques relevant to genomics, including DNA and RNA extraction, PCR, quantitative PCR, gel electrophoresis, and sample quality assessment
• Ability to ensure quality control and to troubleshoot
• Project management and communication

Careers

SEARCH FOR JOBS